A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
Background: There are no previous reports of paliperidone palmitate's (PP) long term tolerability or pharmacokinetics of the highest dose in patients with schizophrenia. This study evaluates safety and tolerability, as well as pharmacokinetics, of the highest marketed dose of PP (150 mg eq. 234...
Saved in:
Main Authors: | Coppola, D., Liu, Y.N., Gopal, S., Remmerie, B., Samtani, M.N., Hough, D.W., Nuamah, I., Sulaiman, A., Pandina, G. |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central
2012
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/10978/1/Coppola-2012-A_one-year_prospecti.pdf http://eprints.um.edu.my/10978/ http://www.biomedcentral.com/1471-244X/12/26/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
by: Coppola, Danielle, et al.
Published: (2012) -
Asian subgroup analysis of the REMISSIO study: A long-term efficacy and safety study of paliperidone palmitate 3-month formulation in patients with stable schizophrenia in a naturalistic clinical setting
by: Chung, Young-Chul, et al.
Published: (2022) -
Non-fatal paliperidone overdose: A case report
by: Gill, J.S., et al.
Published: (2010) -
A preliminary study of neuregulin 1 gene expression in schizophrenia patients on paliperidone in a Malaysian population in University Malaya Medical Centre (UMMC) /
Nazariah Aiza Harun
by: Nazariah Aiza, Harun
Published: (2012) -
Pharmacokinetics And Pharmacodynamics Modeling Of Clozapine In Healthy Volunteers And Patients With Schizophrenia Spectrum Disorders Using Pharmacometrics Approach
by: Orwa, Albitar
Published: (2022)